Benzylpiperazine: the New Zealand legal perspective.

Tools

BASSINDALE, Thomas (2011). Benzylpiperazine: the New Zealand legal perspective. Drug Testing and Analysis, 3 (7-8), 428-429. [Article]

Abstract
More Information
Metrics
Share

[+][-]

Abstract

In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.

More Information

Research Institute, Centre or Group - Does NOT include content added after October 2018:

Biomedical Research Centre

Page Range:

428-429

Identifiers

Identification Number:

10.1002/dta.314

ORCID:

https://orcid.org/0000-0002-4023-6478